|
BioCat GmbH is a private company founded in the year 2000. BioCat supplies innovative products and services for life science research in an application- and customer-oriented way with focus on oncology, diabetes and obesity, neurodegenerative and cardiovascular diseases as well as osteology. The product offering comprises a wide range of high-quality research reagents and cutting-edge technologies in the fields of genomics, proteomics, and cell biology. For tissue-related applications, tissue microarrays as well as RNA, cDNA, and proteins isolated from a wide variety of common and hard-to-obtain tissues are available. Fluorescent proteins, a large selection of antibodies, ELISA kits, cell-based assays, PCR reagents and tools for microRNA, epigenetics and stem cell research complement the portfolio. The products and services provided have been developed by partners in Canada, Germany, Korea, Russia, and the US. They are made available through BioCat to researchers in academia as well as in pharma and biotech industry. Moreover, BioCat is aiming at the co-development of new products based on innovations generated in Germany, such as the production of protein arrays by Laser Induced Forward Transfer (LIFT) of proteins onto substrates.
|